Reviva Pharmaceuticals Inc. has made significant strides in developing a new treatment for schizophrenia, a complex brain disorder that affects approximately 24 million people worldwide, including...
Reviva Pharmaceuticals Inc. has made significant progress in the development of a novel drug aimed at treating schizophrenia, a complex brain disorder affecting approximately 24 million...
